Hypertension in pregnancy · 2009
Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.
Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ohkuchi Akihide, Hirashima Chikako, Matsubara Shigeki, Suzuki Hirotada, Takahashi Kayo, Usui Rie, Suzuki Mitsuaki
Аннотация
OBJECTIVE: It was recently reported that both a high soluble fms-like tyrosine kinase 1 (sFlt1): placental growth factor (PlGF) ratio (sFlt1:PlGF ratio) and high soluble endoglin (sEng) levels are related to the later occurrence of preeclampsia. We compared the serum sFlt1:PlGF ratio, PlGF and sEng levels in women with gestational proteinuria (GP) to those in women with preeclampsia.
METHODS: Seven women with GP and 34 women with preeclampsia were recruited in this study. The 95(th) percentile values in the reference curves of sFlt1, sFlt1:PlGF ratio and sEng, and the 5(th) percentile values in the reference curve of PlGF were respectively set as the cutoff values.
RESULTS: The incidence rates of a high sFlt1:PlGF ratio, low PlGF and high sEng in women with GP were 57%, 29% and 86%, respectively, whereas those in women with preeclampsia were 94%, 77%, and 88%, respectively (p=0.028, p=0.024, and p=1.000, respectively). The incidence rates of a both high sFlt1:PlGF ratio and high sEng in women with GP and preeclampsia were 57% and 88%, respectively (p=0.082).
CONCLUSION: The majority of women with GP showed both increases of the sFlt1:PlGF ratio and sEng, thus suggesting some women with GP may represent subclinical preeclampsia. In addition, women with GP showed a significantly lower sFlt1:PlGF ratio and higher PlGF level than those with preeclampsia, suggesting that the PlGF level is a key regulator for developing hypertension in some pregnant women, even with increases of both sFlt1:PlGF ratio and sEng levels.
METHODS: Seven women with GP and 34 women with preeclampsia were recruited in this study. The 95(th) percentile values in the reference curves of sFlt1, sFlt1:PlGF ratio and sEng, and the 5(th) percentile values in the reference curve of PlGF were respectively set as the cutoff values.
RESULTS: The incidence rates of a high sFlt1:PlGF ratio, low PlGF and high sEng in women with GP were 57%, 29% and 86%, respectively, whereas those in women with preeclampsia were 94%, 77%, and 88%, respectively (p=0.028, p=0.024, and p=1.000, respectively). The incidence rates of a both high sFlt1:PlGF ratio and high sEng in women with GP and preeclampsia were 57% and 88%, respectively (p=0.082).
CONCLUSION: The majority of women with GP showed both increases of the sFlt1:PlGF ratio and sEng, thus suggesting some women with GP may represent subclinical preeclampsia. In addition, women with GP showed a significantly lower sFlt1:PlGF ratio and higher PlGF level than those with preeclampsia, suggesting that the PlGF level is a key regulator for developing hypertension in some pregnant women, even with increases of both sFlt1:PlGF ratio and sEng levels.